 The main focus of our research here is within biotechnology, especially the area called medical biotechnology. So what we basically do is that we take the soldiers of the body, the antibodies, and we take them out of your body and into the lab, and in the lab we can generate more and new soldiers to fight disease in a better way. We have made many great achievements within my lab. I would say the most important within recent years has been the generation of technologies or development of technologies by which it's possible to generate antibodies against one single rare cells in a heterogeneous population. For example, a circulating cancer cell in the blood of a cancer patient. On the screen we are looking at cells taken from a colon cancer patient. What you see is the cells from the blood of the colon cancer patient. In yellow you see the cancer cells. These cells are yellow because we made them yellow by the antibodies that we have created. The goals of our research is to contribute to the area called biopharmaceuticals. Within this area therapeutic antibody reached a sale in 2013 of $63.5 billion. This is around 20% of the Danish gross national product. We would like to contribute to this market.